Identify the initial action by the ER nurse that is most appropriate for a 42-year-old woman diagnosed with a mood disturbance disorder who overdoses on amitriptyline (Elavil)
a. Induce vomiting by administering 30 mL of syrup of Ipecac.
b. Initiate an IV of normal saline at 200 mL per hour.
c. Lavage the stomach with a #14 nasogas-tric tube to prevent trauma.
d. Administer activated charcoal 50 g every 4 hours for 24 hours.
D
You might also like to view...
Which of the following current issues are leading the World Health Organization (WHO) to reconsider its initial definition of health? (Select all that apply.)
a. Environmental issues such as industrial toxins or carcinogenic commercial products b. Global, not local, problems such as spread of antibiotic-resistant bacteria c. Need to move from containment and treatment to social intervention d. Pressure from industrialized nations to emphasize chronic diseases rather than infectious diseases e. Realization that government actions influence the basic human right of health f. Worldwide pandemics such as human immunodeficiency virus (HIV) and swine flu, which require a different approach
Fein v. Permanente Medical Group is important as the case defined the standard of care for the advanced practice nurse. How was that standard of care defined?
1. The medical standard of care 2. The nursing standard of care 3. The advanced nurse practitioner standard of care 4. The specialty nurse standard of care
A client receives a diagnosis of major depression and is prescribed imipramine (Tofranil). What information specifically related to this class of antidepressants should a nurse plan to include in client and family education?
A) The medication may cause dry mouth. B) The medication may cause nausea. C) The medication should not be discontinued abruptly. D) The medication may cause photosensitivity.
In 1997, the Food and Drug Administration Modernization Act was passed. What was the rationale for this legislation?
1. To prove that all adult medications are safe for children 2. To improve testing and labeling of pediatric drugs 3. To encourage the production of more pediatric drugs 4. To generate higher profits for pharmaceutical companies marketing pediatric drugs